Profile picture

Associate Professor Francisco Marin

Virgen de la Arrixaca University Hospital, Murcia (Spain)
Membership: EHRA Member
Follow
Logo ESC

Contributor content

There is a role for anticoagulation in patients with HFrEF in sinus rhythm: pro
Presentation
There is a role for anticoagulation in patients with HFrEF in sinus rhythm: pro
Read more
Predictors of adverse clinical outcomes in atrial fibrillation patients with concomitant renal impairment under rivaroxaban therapy
Presentation
Predictors of adverse clinical outcomes in atrial fibrillation patients with concomitant renal impairment under rivaroxaban therapy
Read more
Impact of potent P2Y12 inhibitors in adverse events reduction in diabetic patients with Acute Coronary Syndromes. An analysis from ACHILLES Registry.
Presentation
Impact of potent P2Y12 inhibitors in adverse events reduction in diabetic patients with Acute Coronary Syndromes. An analysis from ACHILLES Registry.
Read more
Arrhythmia management and device therapies in endocrine disorders
Presentation
Arrhythmia management and device therapies in endocrine disorders
Read more
Use of multiple biomarkers to improve CHA2DS2-VASc and HAS-BLED scores in the prediction of thromboembolic and bleeding events.
Presentation
Use of multiple biomarkers to improve CHA2DS2-VASc and HAS-BLED scores in the prediction of thromboembolic and bleeding events.
Read more
Dealing with left atrial appendage clot
Presentation
Dealing with left atrial appendage clot
Read more
The influence of obesity and sleep apnea on atrial fibrillation
Presentation
The influence of obesity and sleep apnea on atrial fibrillation
Read more
Galentin 3 as marker of interstitial atrial remodeling involved in atrial fibrillation
Presentation
Galentin 3 as marker of interstitial atrial remodeling involved in atrial fibrillation
Read more
Management of acute coronary syndrome in the elderly: comparison of antiplatelet treatment, revascularization rates and outcome
Presentation
Management of acute coronary syndrome in the elderly: comparison of antiplatelet treatment, revascularization rates and outcome
Read more
Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: results of a prospective study with rivaroxaban (X-TRA) biomarker substudy
Presentation
Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: results of a prospective study with rivaroxaban (X-TRA) biomarker substudy
Read more

ESC 365 is supported by

novartis Explore sponsored resources